On the other hand, we conclude that macrophages may remain in the anti-tumoral state in types of cancer that exhibit less TP53 mutation, like colorectal cancer; in these cases, macrophages’ immunotherapy may be more suitable. The gene discussed is TP53; the disease is colorectal cancer.